David Rombaut

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• Integrated analysis of post-transcriptional regulations reveals insights into acute myeloid leukemia.⚑
  2025 L1 32/100 ⚑

1 assessed by us (0 reproduced) · 14 not yet assessed — every PubMed paper on record, linked below.

• Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower‐risk myelodysplastic syndromes ↗

  HemaSphere · 2025 · PMID 39850648
  not yet assessed
• RAPID FIRE SESSION 01 ↗

  Leukemia Research · 2025
  not yet assessed
• MDS BIOLOGY AND PATHOGENESIS - IMMUNE DEREGULATION / INFLAMMATION ↗

  Leukemia Research · 2025
  not yet assessed
• Integrated analysis of post-transcriptional regulations reveals insights into acute myeloid leukemia⚑

  Communications Biology · 2025 · PMID 41407883
  L1 32/100 ⚑
• Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutation ↗

  Nature Communications · 2024 · PMID 38589367
  not yet assessed
• Early Versus Late Onset of ESA in Lower Risk Anemic MDS Patients: Results of the GFM Randomized Phase III EPO-Pretar Trial ↗

  Blood · 2024
  not yet assessed
• FOXP1 regulates oxidative stress, SIRT1 expression, and resistance to chemotherapies in acute myeloid leukemia cells ↗

  Blood Advances · 2023 · PMID 36930820
  not yet assessed
• Somatic Mutations and DNA Hypermethylation at Enhancers and Promoters Identify Distinct Subtypes within Lower-Risk Myelodysplastic Syndromes ↗

  Blood · 2023
  not yet assessed
• S169: MODULATION OF THE IMMUNE LANDSCAPE IN LOWER-RISK MYELODYSPLASTIC SYNDROMES WITH IMETELSTAT-INDUCED TRANSFUSION INDEPENDENCY ↗

  HemaSphere · 2023
  not yet assessed
• DNA Replication Stress Due to Loss of R-Loops in Myelodysplastic Syndromes with <i>SF3B1</i> Mutation ↗

  Blood · 2022
  not yet assessed
• The<i>CADM1</i>tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11 ↗

  Blood Advances · 2021 · PMID 34638130
  not yet assessed
• Comprehensive Analysis of Transcript and Protein Relative Abundance During Blood Stages of <i>Plasmodium falciparum</i> Infection ↗

  Journal of Proteome Research · 2021 · PMID 33475364
  not yet assessed
• A variant erythroferrone disrupts iron homeostasis in <i>SF3B1</i> -mutated myelodysplastic syndrome ↗

  Science Translational Medicine · 2019 · PMID 31292266
  not yet assessed
• From genomic to LC-MS/MS evidence: Analysis of PfEMP1 in Benin malaria cases ↗

  PLoS ONE · 2019 · PMID 31251748
  not yet assessed
• Genomic from <i>Plasmodium falciparum</i> field isolates from Benin allows the identification of PfEMP1 variants by LC-MS/MS at the patient’s level ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2018
  not yet assessed